Deprescribing Considerations for Central Nervous System-active Polypharmacy in Patients with Dementia

Overview

Journal J Am Geriatr Soc

Specialty Geriatrics

Date 2024 Nov 27

PMID 39600114

Authors

Anna Hung

Matthew E Growdon

Affiliations

Soon will be listed here.

References

Vordenberg S, Davis R, Strominger J, Marcus S, Kim H, Blow F . Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United States. J Am Geriatr Soc. 2024; 73(2):422-430. PMC: 11826002. DOI: 10.1111/jgs.19256. View

Hung A, Bush C, Greiner M, Campbell H, Hammill B, Maciejewski M . Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. J Manag Care Spec Pharm. 2020; 26(2):169-175. PMC: 10077839. DOI: 10.18553/jmcp.2020.26.2.169. View

Maust D, Strominger J, Bynum J, Langa K, Gerlach L, Zivin K . Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US. JAMA. 2020; 324(7):706-708. PMC: 7435346. DOI: 10.1001/jama.2020.8519. View

Field T, Gurwitz J, Harrold L, Rothschild J, Debellis K, Seger A . Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004; 52(8):1349-54. DOI: 10.1111/j.1532-5415.2004.52367.x. View

Growdon M, Hunt L, Miller M, Halim M, Karliner L, Gonzales R . eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators. J Gen Intern Med. 2024; 39(13):2461-2470. PMC: 11436619. DOI: 10.1007/s11606-024-08899-0. View

Sun E, Dixit A, Humphreys K, Darnall B, Baker L, Mackey S . Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017; 356:j760. PMC: 5421443. DOI: 10.1136/bmj.j760. View

. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023; 71(7):2052-2081. DOI: 10.1111/jgs.18372. View

Wright R, Roumani Y, Boudreau R, Newman A, Ruby C, Studenski S . Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. J Am Geriatr Soc. 2009; 57(2):243-50. PMC: 2744424. DOI: 10.1111/j.1532-5415.2008.02127.x. View

Growdon M, Espejo E, Jing B, Boscardin W, Zullo A, Yaffe K . Attitudes toward deprescribing among older adults with dementia in the United States. J Am Geriatr Soc. 2022; 70(6):1764-1773. PMC: 9177826. DOI: 10.1111/jgs.17730. View

10.

Rawle M, Cooper R, Kuh D, Richards M . Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. J Am Geriatr Soc. 2018; 66(5):916-923. PMC: 6001617. DOI: 10.1111/jgs.15317. View

11.

Gray S, Marcum Z, Dublin S, Walker R, Golchin N, Rosenberg D . Association Between Medications Acting on the Central Nervous System and Fall-Related Injuries in Community-Dwelling Older Adults: A New User Cohort Study. J Gerontol A Biol Sci Med Sci. 2019; 75(5):1003-1009. PMC: 7164522. DOI: 10.1093/gerona/glz270. View

12.

Gnjidic D, Hilmer S, Blyth F, Naganathan V, Waite L, Seibel M . Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012; 65(9):989-95. DOI: 10.1016/j.jclinepi.2012.02.018. View

13.

Maust D, Strominger J, Kim H, Langa K, Bynum J, Chang C . Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021; 325(10):952-961. PMC: 7944381. DOI: 10.1001/jama.2021.1195. View

14.

Doherty A, Boland P, Reed J, Clegg A, Stephani A, Williams N . Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020; 4(3). PMC: 7465575. DOI: 10.3399/bjgpopen20X101096. View

15.

Growdon M, Gan S, Yaffe K, Steinman M . Polypharmacy among older adults with dementia compared with those without dementia in the United States. J Am Geriatr Soc. 2021; 69(9):2464-2475. PMC: 8440349. DOI: 10.1111/jgs.17291. View